Immunomodulation by platelet-derived DKK1: potential for controlling disease and pathology in leishmaniasis and implications for other infectious diseases

• by Olivia C. Ihedioha, Diane McMahon-Pratt, Alfred L. M. Bothwell

• June 2, 2026

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

• June 2, 2026

• 5 min

Partisan and Geographic Variation in Emotional Responses to COVID-19 Vaccination on Social Media

• by Kokil Jaidka, Yuanyuan Wu, Anku Rani, Ozan Kuru, Reyhan Jamalova, Garrick Sherman, Sharath Chandra Guntuku

• June 1, 2026

Japanese Encephalitis Vaccine Decision Aid for Travelers: A Randomized Clinical Trial

• by Sarah L. McGuinness, Owen Eades, Jennifer Morris, Holly Seale, Allen C. Cheng, Karin Leder

• June 1, 2026